100
Participants
Start Date
September 1, 2024
Primary Completion Date
March 31, 2025
Study Completion Date
April 1, 2025
Levofloxacin-Based H. pylori Eradication Therapy
"This intervention consists of a 14-day levofloxacin-based triple therapy regimen for Helicobacter pylori eradication in ITP patients. The regimen follows current ACG guidelines and typically includes:~Levofloxacin - antibiotic targeting H. pylori~Amoxicillin - antibiotic used in combination for enhanced efficacy~Proton Pump Inhibitor (PPI) - to reduce stomach acid and improve antibiotic effectiveness~Patients will receive the full 14-day course, and platelet counts will be measured at baseline and four weeks post-therapy to assess hematological response. This intervention is unique to H. pylori-positive ITP patients in this study and is not administered to H. pylori-negative patients."
Al-Mustansiriyah University - college of pharmacy - clinical pharmacy department, Baghdad
Al-Mustansiriyah University
OTHER